|TIME||MEETING ROOMS||ACTIVITIES – SEMINARS – SPEAKERS|
Welcome to visit our exhibitors
– Penilla Gunther, Founder of FOKUS Patient®, Sweden
– Gabriel Oniscu, President, ESOT – European Society of Organ Transplantation, professor Karolinska Institute, Sweden
”The European Union – a Health Union?”
– Annika Wäppling Korzinek, Head of European Commission Representation in Sweden
|Hörsalen||PRESENT SITUATION FOR ORGAN DONATION & TRANSPLANTATION IN EUROPE|
– Mirela Busic, Head of SoHO Standards Section (Substances of Human Origin), EDQM – European Directorate for the Quality of Medicines and Healthcare, Council of Europe, France
|INTRODUCTION OF DCD (DONATION AFTER CIRCULATORY DEATH) IN SWEDEN – A PROCESS|
A donor after cardiac death (DCD) is a donor who has suffered devastating and irreversible brain injury and may be near death but does not meet formal brain death criteria. New legislation has made it possible for more donors.
– Professor Annika Tibell, Director of Research and Development & Education, Assistant Director Karolinska University Hospital, Professor in Medical Ethics, Karolinska Institute. Former transplant surgeon, Sweden.
– Dr Carl Jorns, Senior Consultant, Transplantation Surgeon, Head of Liver transplantation, Karolinska University Hospital
– Dr Markus Gäbel, Transplantation Surgeon & Medical Chief Organ Coordination Unit, the Transplantation Centre at Sahlgrenska University Hospital, Gothenburg
|HEALTH DATA IN THE ORGAN DONATION AND TRANSPLANTATION AREA|
The need of attention and research for development of new treatments for people after transplantation is big all over the world, not only new methods for transplantation. The need of follow-ups of transplanted patients over time is important to be able to see what methods and treatments that work or to reduce side-effects by treatments.
- ”Introduction to ESOT on-going work with registries in Europa”
– Devi May, CEO, ESOT – European Society of Organ Transplantation, Italy
- ”How can The European Council and The EU Commission act for better follow-up and registries? ”
– Helena Almén, Swedish representative to the Competent Authorities on Organ Donation and Transplantation, European Commission and Swedish representative to the The European Committee on Organ Transplantation, Council of Europe, Swedish National Board of Welfare
|CANCER AND TRANSPLANTATION|
It has been estimated before, that organ transplanted people to have 2-4 times higher risk (compared with the whole population) for cancer. But the absolute risk for a transplanted patient to develop some kind of cancer, has not been as much explored. It is not often mentioned either, that cancer patients can need a transplantation as a life-saving treatment.
- ”Can transplanted patients be treated with immunotherapy?
– Professor Gunilla Enblad, Department of Immunology, Genetics and Pathology, Uppsala University
– Lise-lott Eriksson, President, Myeloma Patients Europe
|CANCER RISK AND SURVIVAL AFTER TRANSPLANTATION|
Common cancer types, their prognoses and what treatment to expect
– Dr Henrik Benoni, Transplantation Surgeon, Section of Transplantation Surgery at Akademiska Hospital, Uppsala, Sweden
|ALL AGES NEED TRANSPLANTATIONS|
To be waiting for a new organ is a life-changing experience for all people independent of age, but also for family and friends. How can we dares to talk more about the importance of donation and what a transplantation can mean to a person in need?
– Dr Heidi Stensmyren, Past President of the World Medical Association, Chief Medical Officer at Cellcolabs. Former Managing Director Women’s Health and Allied Health Professionals at Karolinska Hospital, Stockholm and Chair of The national council of organ- and tissue donation
- ”What do we need to create more awareness about donation from children?”
– Mattias Barsk, Communication Manager Hjärtebarnsfonden
– Paola Palacios, Founder & President #Förallabarnpålistan
- ”The experience of the need of a transplantation for the individuals and their families”
– Anette von Koch, President, National Organisation for Heart & Lung Transplanted Patients, VIKING
|TRANSPLANTATION – THE START OF A NEW LIFE, BUT WHAT HAPPENS THEN?|
Transplantation is often talked about as a lifesaving treatment but more has to be done to foresee risks and to reduce side effects of the life-long medication for transplanted people. What’s going on in R&D?
- ”The need from a medical perspective”
– Dr Muhammad Khurram, Transplant and vascular access kirurg, Royal London hospital, Bart’s Health, London, England
- ”Innovativa läkemedel & med tech inom transplantationsområdet”
– Thomas Allvin, Executive Director Strategy & Healthcare systems, EFPIA – European Federation of Pharmaceuticals Industries Associations, Belgien
– Anna Lefevre Skjöldebrand, CEO Swedish Medtech
|ALTERNATIVES TO HUMAN ORGANS AND TISSUES|
The research moves forward in opportunities for people in need of transplantations. When human organs and tissues are not enough, there is a need of new materials and methods.
- ”Bioartificial Pancreas to Cure Type 1 Diabetes”
– Ekaterine Berishvili, Councillor of ESOT, Tissue Engineering and Organ Regeneration Group Leader, University of Geneva
- ”Lung Regeneration for Transplantation – Strategies to Expand the Lung Donor Pool”
– Professor Sandra Lindstedt, Consultant in Cardiothoracic and Transplantation, Lund University Hospital, Sweden
|A LIFE THAT IS GAINED SHOULD ALSO BE LIVED!|
Many of those who have been transplanted have really got a new life! But is also comes with some routines like a life-long medication and risks that comes with a lower immune system. It is important to be able to live a ”normal” life, especially as young and transplanted.
– Anna Forsberg, Professor Nursing Science and Transplantation Nurse, Lund University Sweden
- ”How can families have more support where a parent or a child is transplanted – or both are?”
– Kathleen Pade, President, Heart- and Lung Transplantation Club, Danmark
- ”Project for the transition between being a transplanted child to adult in health care”
– Gabriela Brandin & Micaela Hamrin, MOD – Mer Organdonation, Sweden
– Penilla Gunther, Founder FOKUS Patient®
|Hörsalen||THEME: LIVING DONORS|
It is more common to speak about the needs of more organs from dead people, but there is a need to create awareness about how living donors can make a difference. Not only kidneys, but also from liver, skin or bone tissue can be taken care of, as well as bone marrow or stem cells. How is the assessment made abd how to increase the numbers of them?
– Professor Gabriel Oniscu, President ESOT, Stockholm Transplantation Centre, Karolinska Institute, Sweden
- ”Transplantation of skin – skin grafting”
– Alexandra Karström, Head of Cell and Tissue Therapy Lab at Plastic Surgery department, Akademiska Hospital, Uppsala, Sweden
- ”To donate stem cells can cure and save lives”
– Nicole Silverstolpe, CEO The Tobias Registry – The Swedish Registry for Blood Stem Cells
|15:00||Hörsalen, plenum||THE PATIENT JOURNEY|
More information coming soon.
Reflections from today’s seminars from a panel
– ESOT Professor Gabriel Oniscu, President
– Swedish Transplantation Society, Dr Carl Jorns, Member of the Board
– Thomas Andersson, Vice President, The Lung Fibroses Association
– Patient represenatives
More information coming soon.
|17:00||THANKS FOR TODAY!|
Registration needed, limited number of seat. Venue TBC.